Search

Your search keyword '"Shankar, Ganesh M."' showing total 423 results

Search Constraints

Start Over You searched for: Author "Shankar, Ganesh M." Remove constraint Author: "Shankar, Ganesh M."
423 results on '"Shankar, Ganesh M."'

Search Results

1. Wearable bio-adhesive metal detector array (BioMDA) for spinal implants

5. Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord

6. Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma

7. Disparities in Surgical Intervention and Health-Related Quality of Life Among Racial/Ethnic Groups With Degenerative Lumbar Spondylolisthesis.

8. Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma

9. Supplementary Fig. S1 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors

10. Supplementary Table S3 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors

11. Data from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors

15. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas

24. CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECONDARY CNS LYMPHOMA AFTER ADOPTIVE IMMUNOTHERAPY WITH CD19-DIRECTED CAR T-CELLS

25. PATH-51. GENETIC CHARACTERIZATION AND MUTATIONAL PROFILING OF FORAMEN MAGNUM MENINGIOMAS: A MULTI-INSTITUTIONAL STUDY

26. Intraoperative integrated diagnostic system for malignant central nervous system tumors

30. Genotype-targeted local therapy of glioma

32. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

34. Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.

37. Supplementary Data from TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas

38. Supplementary Figures 1-6 from The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

39. Supplementary Figure Legends from The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

40. Supplementary Methods from The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

41. Data from The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

42. Supplementary File description from TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas

44. List of Contributors

47. A Rapid Genotyping Assay for CSF Accelerates Diagnosis and Treatment Initiation for CNS Malignancies

49. Assessment of Spinal Metastases Surgery Risk Stratification Tools in Breast Cancer by Molecular Subtype

Catalog

Books, media, physical & digital resources